Failure to treat primary carnitine deficiency infants promptly with intravenous glucose during periods of metabolic decompensation will result in progression to coma and death
Benefits: improved memory, enhanced learning capacity, and long-term neuroprotection
How do providers choose treatment
J Biol Chem 2003;278:25738-44
The right dosing and timing depend on the specific peptides chosen and the patients goals, and they should be set by a clinician rather than guessed at
Canada Europe UK Germany France Italy Spain Russia Asia Pacific China India Japan South Korea Australia Latin America Brazil Mexico MEA UAE Saudi Arabia South Africa Table of Contents Chapter 1 Methodology & Scope Chapter 2 Executive Summary Chapter 3 Industry Insights Chapter 4 Competitive Landscape, 2024 Chapter 5 Market Estimates & Forecast, By Produced, 2021-2034 (USD Million) (Kilo Tons) Chapter 6 Market Estimates & Forecast, By Application, 2021-2034 (USD Million) (Kilo Tons) Chapter 7 Market Estimates & Forecast, By Region, 2021-2034 (USD Million) (Kilo Tons) Chapter 8 Company Profiles Don't see your key competitors
